These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5074089)

  • 1. Deferoxamine in the treatment of porphyria.
    Taxay EP
    South Med J; 1972 Oct; 65(10):1186-212. PubMed ID: 5074089
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E; Schwartze G
    Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical effects of chloroquine therapy in porphyria cutanea tarda.
    Vogler WR; Galambos JT; Olansky S
    Am J Med; 1970 Sep; 49(3):316-21. PubMed ID: 5455563
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)].
    Hocevar V; Rausch-Stroomann JG
    Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative determination of urinary porphyrins using Rimington's and Sveinsson's technic and experience in the therapy of porphyria cutanea tarda using Desferal CIBA].
    Votruba M; Nozicková M; Pazderka J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1969; 12(3):313-9. PubMed ID: 5265982
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and biological effects of chelating agents in porphyria cutanea tarda].
    Thivolet J; Perrot H; Mallein R; Sabater P
    Presse Med (1893); 1968 Feb; 76(8):367-70. PubMed ID: 4967022
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute intermittent porphyria with seizures. Anticonvulsant medication-induced metabolic changes.
    Birchfield RI; Cowger ML
    Am J Dis Child; 1966 Dec; 112(6):561-5. PubMed ID: 5928821
    [No Abstract]   [Full Text] [Related]  

  • 8. [Porphyria cutanea tarda with hypersideremia: effectiveness of desferrioxamine (Desferal)].
    Beurey J; Weber M; Montet Y; Jeandidier P; Barbier JM
    Arch Belg Dermatol Syphiligr; 1966; 22(4):235-41. PubMed ID: 6005619
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Bianco L; Salvadeo A; Barosi G
    Nephrol Dial Transplant; 1992; 7(5):438-42. PubMed ID: 1321381
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of diet in variegate (South African genetic) porphyria.
    Perlroth MG; Tschudy DP; Ratner A; Spaur W; Redeker A
    Metabolism; 1968 Jul; 17(7):571-81. PubMed ID: 5656975
    [No Abstract]   [Full Text] [Related]  

  • 11. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience].
    Zawirska B; Kwiatkowska W; Nowojska A
    Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute intermittent porphyria in Poland.
    Darocha T; Gregor A
    S Afr Med J; 1971 Sep; ():204-17. PubMed ID: 5150281
    [No Abstract]   [Full Text] [Related]  

  • 13. A neurological disorder in porphyria cutanea tarda.
    Asmal AC; Vinik AI; Joubert SM
    S Afr Med J; 1970 Jul; 44(27):781-4. PubMed ID: 4317550
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of deferoxamine capacity to revert a severe porphyria induced by hexachlorobenzene].
    Wainstok de Calmanovici R; Billi SC; Aldonatti CA; San Martín de Viale LC
    Acta Physiol Pharmacol Latinoam; 1987; 37(4):541-54. PubMed ID: 3274026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intermittent porphyria. A clinical, biochemical and family study.
    Kreimer-Birnbaum M; Mosovich LL; Bannerman RM
    J Med; 1971; 2(3):149-66. PubMed ID: 5289639
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of pyridoxine deficiency on porphyrin precursor excretion in acute intermittent porphyria.
    Elder TD; Mengel CE
    Am J Med; 1966 Sep; 41(3):369-74. PubMed ID: 5914112
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
    Marchesi L; Di Padova C; Cainelli T; Reseghetti A; Di Padova F; Rovagnati P; Cantoni L
    Photodermatol; 1984 Dec; 1(6):286-92. PubMed ID: 6398430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Porphyria cutanea tarda: study of the changes in porphyrin metabolism during desferrioxamine therapy].
    Mazza U; Bianco G; Fiorina L; Prato V
    Boll Soc Ital Biol Sper; 1965 Jan; 41(1):2-4. PubMed ID: 5875798
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of bloodletting on the excretion of porphyrius and clelta aminolevulinic acid as well as the clinical picture of porphyria cutanea tarda].
    Broese I; Mattheus A
    Dermatol Monatsschr; 1977 Feb; 163(2):111-8. PubMed ID: 858437
    [No Abstract]   [Full Text] [Related]  

  • 20. Phlebotomy therapy in cutaneous porphyria. Effect on iron and trace metals.
    Walsh JR; Lobitz WC; Mahler DJ; Kingery FA
    Arch Dermatol; 1970 Feb; 101(2):167-72. PubMed ID: 5413253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.